Hansa Biopharma Unveils Promising Findings on Imlifidase for Guillain-Barré Syndrome at 2025 PNS Annual Meeting #Sweden #Lund #Hansa_Biopharma #imlifidase #GBS_Treatment
0
0
0
0
Hansa Biopharma Unveils Promising Findings on Imlifidase for Guillain-Barré Syndrome at 2025 PNS Annual Meeting #Sweden #Lund #Hansa_Biopharma #imlifidase #GBS_Treatment